How does Rosuvastatin influence lipid markers in patients with hepatic steatosis, and what are the implications for reducing cardiovascular risks?
Sahil KapoorExplorer
IVF Questions & Answers
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
How does Rosuvastatin influence lipid markers in patients with hepatic steatosis, and what are the implications for reducing cardiovascular risks?
Rosuvastatin effectively lowers LDL-C and total cholesterol, which can help mitigate cardiovascular risks in hepatic steatosis patients by improving lipid profiles.